For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

RxDx Device for non-small cell lung cancer has received Breakthrough Device Designation from the U.S. Food and Drug ...

Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...

April 22 (UPI) -- Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years.

Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.

Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...

Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...